nach oben

Die Innere Medizin

Erschienen in:

01.09.2010 | CME Weiterbildung · Zertifizierte Fortbildung

Einteilung und Management der oberen gastrointestinalen Blutung

verfasst von: PD Dr. K. Herrlinger

Erschienen in: Die Innere Medizin | Ausgabe 9/2010

Einloggen, um Zugang zu erhalten

Zusammenfassung

Immer noch ist die obere gastrointestinale Blutung die häufigste Notfallsituation in der Gastroenterologie. Wegen der grundsätzlich verschiedenen Therapieansätze wird die Varizenblutung von der nicht-varikösen Blutung unterschieden. Essenziell sowohl für den Zeitpunkt der Endoskopie als auch zur Prognoseabschätzung ist die Risikoabschätzung bezüglich der Wahrscheinlichkeit einer Rezidivblutung, entsprechende Kriterien werden in dieser Arbeit diskutiert. Die modernen Therapieverfahren für beide Blutungssituationen werden mit ihren jeweiligen Erfolgsraten, aber auch Komplikationsrisiken dargestellt.

Aabakken L (2008) Endoscopic haemostasis. Best Pract Res Clin Gastroenterol 22:899–927PubMedCrossRef

Abid S, Jafri W, Hamid S et al (2009) Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial. Am J Gastroenterol 104:617–623PubMedCrossRef

Banares R, Albillos A, Rincon D et al (2002) Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 35:609–615PubMedCrossRef

Bernard B, Grange JD, Khac EN et al (1999) Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 29:1655–1661PubMedCrossRef

Bianco MA, Rotondano G, Marmo R et al (2004) Combined epinephrine and bipolar probe coagulation vs. bipolar probe coagulation alone for bleeding peptic ulcer: a randomized, controlled trial. Gastrointest Endosc 60:910–915PubMedCrossRef

Brullet E, Calvet X, Campo R et al (1996) Factors predicting failure of endoscopic injection therapy in bleeding duodenal ulcer. Gastrointest Endosc 43:111–116PubMedCrossRef

Brullet E, Campo R, Calvet X et al (1996) Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer. Gut 39:155–158PubMedCrossRef

Carbonell N, Pauwels A, Serfaty L et al (2006) Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Am J Gastroenterol 101:1211–1215PubMedCrossRef

Celinski K, Cichoz-Lach H, Madro A et al (2008) Non-variceal upper gastrointestinal bleeding–guidelines on management. J Physiol Pharmacol 59 (Suppl 2):215–229PubMed

10.

Cheng LF, Wang ZQ, Li CZ et al (2007) Treatment of gastric varices by endoscopic sclerotherapy using butyl cyanoacrylate: 10 years‘ experience of 635 cases. Chin Med J (Engl) 120:2081–2085

11.

Chou YC, Hsu PI, Lai KH et al (2003) A prospective, randomized trial of endoscopic hemoclip placement and distilled water injection for treatment of high-risk bleeding ulcers. Gastrointest Endosc 57:324–328PubMedCrossRef

12.

Cipolletta L, Bianco MA, Rotondano G et al (2002) Outpatient management for low-risk nonvariceal upper GI bleeding: a randomized controlled trial. Gastrointest Endosc 55:1–5PubMedCrossRef

13.

Coffin B, Pocard M, Panis Y et al (2002) Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointest Endosc 56:174–179PubMedCrossRef

14.

Czernichow P, Hochain P, Nousbaum JB et al (2000) Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas. Eur J Gastroenterol Hepatol 12:175–181PubMedCrossRef

15.

Dorward S, Sreedharan A, Leontiadis GI et al (2006) Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev CD005415

16.

Fernandez J, Ruiz Arbol L del, Gomez C et al (2006) Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 131:1049–1056PubMedCrossRef

17.

Feu F, Ruiz Arbol L del, Banares R et al (1996) Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group. Gastroenterology 111:1291–1299PubMedCrossRef

18.

Fleig WE, Lotterer E, Kleber G et al (2000) Endoskopische Therapie der oberen gastrointestinalen Blutung. Internist (Berl) 41:1031–1040

19.

Forrest JA, Finlayson ND, Shearman DJ (1974) Endoscopy in gastrointestinal bleeding. Lancet 2:394–397PubMedCrossRef

20.

Frossard JL, Spahr L, Queneau PE et al (2002) Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology 123:17–23PubMedCrossRef

21.

García-Pagán JC, Caca K, Bureau C et al (2010) Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362:2370–2379PubMedCrossRef

22.

Gevers AM, De Goede E, Simoens M et al (2002) A randomized trial comparing injection therapy with hemoclip and with injection combined with hemoclip for bleeding ulcers. Gastrointest Endosc 55:466–469PubMedCrossRef

23.

Graham DY, Smith JL (1981) The course of patients after variceal hemorrhage. Gastroenterology 80:800–809PubMed

24.

Havanond C, Havanond P (2005) Argon plasma coagulation therapy for acute non-variceal upper gastrointestinal bleeding. Cochrane Database Syst Rev CD003791

25.

Hou MC, Lin HC, Liu TT et al (2004) Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 39:746–753PubMedCrossRef

26.

Hsu PI, Lo GH, Lo CC et al (2004) Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers. World J Gastroenterol 10:3666–3669PubMed

27.

Hubmann R, Bodlaj G, Czompo M et al (2006) The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy 38:896–901PubMedCrossRef

28.

Hui WM, Ng MM, Lok AS et al (1991) A randomized comparative study of laser photocoagulation, heater probe, and bipolar electrocoagulation in the treatment of actively bleeding ulcers. Gastrointest Endosc 37:299–304PubMedCrossRef

29.

Jensen DM, Pace SC, Soffer E et al (2006) Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study. Am J Gastroenterol 101:1991–1999PubMedCrossRef

30.

Kahi CJ, Jensen DM, Sung JJ et al (2005) Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis. Gastroenterology 129:855–862PubMedCrossRef

31.

Khuroo MS, Khuroo NS, Farahat KL et al (2005) Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 21:347–361PubMedCrossRef

32.

Khuroo MS, Yattoo GN, Javid G et al (1997) A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 336:1054–1058PubMedCrossRef

33.

Lai KH, Peng SN, Guo WS et al (1994) Endoscopic injection for the treatment of bleeding ulcers: local tamponade or drug effect? Endoscopy 26:338–341PubMedCrossRef

34.

Laine L, Cook D (1995) Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 123:280–287PubMed

35.

Laine L, McQuaid KR (2009) Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol 7:33–47PubMedCrossRef

36.

Laine L, Peterson WL (1994) Bleeding peptic ulcer. N Engl J Med 331:717–727PubMedCrossRef

37.

Lau JY, Leung WK, Wu JC et al (2007) Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med 356:1631–1640PubMedCrossRef

38.

Lau JY, Sung JJ, Lam YH et al (1999) Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med 340:751–756PubMedCrossRef

39.

Lau JY, Sung JJ, Lee KK et al (2000) Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 343:310–316PubMedCrossRef

40.

Lee JG, Turnipseed S, Romano PS et al (1999) Endoscopy-based triage significantly reduces hospitalization rates and costs of treating upper GI bleeding: a randomized controlled trial. Gastrointest Endosc 50:755–761PubMedCrossRef

41.

Leontiadis GI, Sharma VK, Howden CW (2007) Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials. Mayo Clin Proc 82:286–296PubMed

42.

Levacher S, Letoumelin P, Pateron D et al (1995) Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 346:865–868PubMedCrossRef

43.

Lin HJ, Hsieh YH, Tseng GY et al (2002) A prospective, randomized trial of endoscopic hemoclip versus heater probe thermocoagulation for peptic ulcer bleeding. Am J Gastroenterol 97:2250–2254PubMedCrossRef

44.

Lin HJ, Tseng GY, Perng CL et al (1999) Comparison of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleeding. Gut 44:715–719PubMedCrossRef

45.

Lin HJ, Wang K, Perng CL et al (1995) Heater probe thermocoagulation and multipolar electrocoagulation for arrest of peptic ulcer bleeding. A prospective, randomized comparative trial. J Clin Gastroenterol 21:99–102PubMedCrossRef

46.

Liou TC, Chang WH, Wang HY et al (2007) Large-volume endoscopic injection of epinephrine plus normal saline for peptic ulcer bleeding. J Gastroenterol Hepatol 22:996–1002PubMedCrossRef

47.

Lo CC, Hsu PI, Lo GH et al (2006) Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcers. Gastrointest Endosc 63:767–773PubMedCrossRef

48.

Lo GH, Chen WC, Wang HM et al (2009) Low-dose terlipressin plus banding ligation versus low-dose terlipressin alone in the prevention of very early rebleeding of oesophageal varices. Gut 58:1275–1280PubMedCrossRef

49.

Longstreth GF (1995) Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 90:206–210PubMed

50.

Longstreth GF, Feitelberg SP (1998) Successful outpatient management of acute upper gastrointestinal hemorrhage: use of practice guidelines in a large patient series. Gastrointest Endosc 47:219–222PubMedCrossRef

51.

Lui HF, Stanley AJ, Forrest EH et al (2002) Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 123:735–744PubMedCrossRef

52.

Marmo R, Rotondano G, Bianco MA et al (2003) Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis. Gastrointest Endosc 57:62–67PubMedCrossRef

53.

Merli M, Nicolini G, Angeloni S et al (2003) Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 38:266–272PubMedCrossRef

54.

North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices (1988) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 319:983–989CrossRef

55.

Ohmann C, Imhof M, Ruppert C et al (2005) Time-trends in the epidemiology of peptic ulcer bleeding. Scand J Gastroenterol 40:914–920PubMedCrossRef

56.

Papatheodoridis GV, Goulis J, Leandro G et al (1999) Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology 30:612–622PubMedCrossRef

57.

Park CH, Lee SJ, Park JH et al (2004) Optimal injection volume of epinephrine for endoscopic prevention of recurrent peptic ulcer bleeding. Gastrointest Endosc 60:875–880PubMedCrossRef

58.

Pescatore P, Jornod P, Borovicka J et al (2002) Epinephrine versus epinephrine plus fibrin glue injection in peptic ulcer bleeding: a prospective randomized trial. Gastrointest Endosc 55:348–353PubMedCrossRef

59.

Peter S, Wilcox CM (2008) Modern endoscopic therapy of peptic ulcer bleeding. Dig Dis 26:291–299PubMedCrossRef

60.

Pinto-Marques P, Romaozinho JM, Ferreira M et al (2006) Esophageal perforation–associated risk with balloon tamponade after endoscopic therapy. Myth or reality? Hepatogastroenterology 53:536–539PubMed

61.

Pohl H, Finlayson SR, Sonnenberg A et al (2005) Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment? Aliment Pharmacol Ther 22:529–537PubMedCrossRef

62.

Rockall TA, Logan RF, Devlin HB et al (1995) Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering committee and members of the national audit of acute upper gastrointestinal haemorrhage. BMJ 311:222–226PubMedCrossRef

63.

Rockall TA, Logan RF, Devlin HB, Northfield TC (1996) Risk assessment after acute upper gastrointestinal haemorrhage. Gut 38:316–321PubMedCrossRef

64.

Rutgeerts P, Rauws E, Wara P et al (1997) Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer. Lancet 350:692–696PubMedCrossRef

65.

Schepke M, Kleber G, Nurnberg D et al (2004) Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 40:65–72PubMedCrossRef

66.

Schmitz RJ, Sharma P, Badr AS et al (2001) Incidence and management of esophageal stricture formation, ulcer bleeding, perforation, and massive hematoma formation from sclerotherapy versus band ligation. Am J Gastroenterol 96:437–441PubMedCrossRef

67.

Silverstein FE, Gilbert DA, Tedesco FJ et al (1981) The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors. Gastrointest Endosc 27:80–93PubMedCrossRef

68.

Skok P (1998) The epidemiology of hemorrhage from the upper gastrointestinal tract in the mid-nineties–has anything changed? Hepatogastroenterology 45:2228–2233PubMed

69.

Song SY, Chung JB, Moon YM et al (1997) Comparison of the hemostatic effect of endoscopic injection with fibrin glue and hypertonic saline-epinephrine for peptic ulcer bleeding: a prospective randomized trial. Endoscopy 29:827–833PubMedCrossRef

70.

Sung JJ, Barkun A, Kuipers EJ et al (2009) Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med 150:455–464PubMed

71.

Tan PC, Hou MC, Lin HC et al (2006) A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology 43:690–697PubMedCrossRef

72.

Thomopoulos KC, Theocharis GJ, Vagenas KA et al (2004) Predictors of hemostatic failure after adrenaline injection in patients with peptic ulcers with non-bleeding visible vessel. Scand J Gastroenterol 39:600–604PubMedCrossRef

73.

Tripathi D, Ferguson JW, Kochar N et al (2009) Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology 50:825–833PubMedCrossRef

74.

Vergara M, Calvet X, Gisbert JP (2007) Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcers. Cochrane Database Syst Rev CD005584

75.

Vreeburg EM, Terwee CB, Snel P et al. (1999) Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut 44:331–335PubMedCrossRef

76.

Walker S, Kreichgauer HP, Bode JC (1992) Terlipressin vs. somatostatin in bleeding esophageal varices: a controlled, double-blind study. Hepatology 15:1023–1030PubMedCrossRef

77.

Wong SK, Yu LM, Lau JY et al (2002) Prediction of therapeutic failure after adrenaline injection plus heater probe treatment in patients with bleeding peptic ulcer. Gut 50:322–325PubMedCrossRef

78.

Yuan Y, Wang C, Hunt RH (2008) Endoscopic clipping for acute nonvariceal upper-GI bleeding: a meta-analysis and critical appraisal of randomized controlled trials. Gastrointest Endosc 68:339–351PubMedCrossRef

79.

Zehetner J, Shamiyeh A, Wayand W et al (2008) Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent. Surg Endosc 22:2149–2152PubMedCrossRef

Titel: Einteilung und Management der oberen gastrointestinalen Blutung
verfasst von: PD Dr. K. Herrlinger
Publikationsdatum: 01.09.2010
Verlag: Springer-Verlag
Erschienen in: Die Innere Medizin / Ausgabe 9/2010
Print ISSN: 2731-7080
Elektronische ISSN: 2731-7099
DOI: https://doi.org/10.1007/s00108-010-2590-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

NSCLC: Progressionsfreies Überleben unter Osimertinib fast versiebenfacht

06.06.2024 ASCO 2024 Kongressbericht

Erste Ergebnisse der Phase-III-Studie LAURA etablieren Osimertinib als neuen Therapiestandard für Menschen mit nicht-resezierbarem, EGFR-mutiertem, nicht-kleinzelligem Lungenkarzinom im Stadium III, die nach definitiver Radiochemotherapie progressionsfrei sind. Auf der ASCO-Tagung wurden diese beeindruckenden Ergebnisse besprochen.

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gute molekulare Response, aber seltener ernste Nebenwirkungen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2010

Kongresse des BDI

Neue Therapieoption bei M. Crohn

Progrediente Erblindung einer jungen Patientin mit extremer Adipositas

Mitteilungen BDI

Das von Willebrand-Syndrom